CARDIACCS AS

Their core work

CARDIACCS AS is a Norwegian medical technology SME that develops sensor systems for continuous cardiac monitoring during and after surgery. Their core product line uses accelerometer-based technology to measure heart contractility and function in critical care patients. They also work on advanced materials for cardiac device encapsulation, including pace lead and sensor packaging, bridging medical device development with electronics and materials engineering.

What they specialise in

How they've shifted over time

CARDIACCS began with computational cardiology and early-stage sensor feasibility (CARDISENSE Phase 1 in 2015, PIC from 2017). From 2018 onward, they shifted toward hardware development and manufacturing challenges — building a full accelerometer-based monitoring system (SAMBAfun), developing encapsulation materials (MATPASE), and engaging with advanced electronics packaging (APPLAUSE). The trajectory shows a classic medtech SME journey from concept validation to product engineering and manufacturing readiness.

CARDIACCS is moving from research into product-ready cardiac monitoring hardware, increasingly focused on materials, packaging, and manufacturing — signaling readiness for clinical deployment and commercialization partnerships.

How they like to work

CARDIACCS leads most of its projects (3 out of 5 as coordinator), indicating confidence in driving project agendas and managing consortia. Despite being a small company, they have built a broad network of 53 partners across 15 countries, suggesting they are well-connected in both the medtech and sensor technology communities. Their participation in large research networks (PIC, APPLAUSE) alongside their own coordinated projects shows they balance leadership with strategic partnering where complementary expertise is needed.

CARDIACCS has collaborated with 53 unique partners across 15 countries, an impressively wide network for an SME with only 5 projects. This breadth reflects their position at the intersection of medical devices, sensor technology, and advanced manufacturing, drawing partners from multiple domains.

What sets them apart

CARDIACCS occupies a specific niche: accelerometer-based cardiac monitoring for surgical and critical care settings — a space with very few dedicated SMEs in Europe. Their combination of sensor hardware development, biocompatible materials expertise, and computational cardiology connections makes them a rare bridge between medical device engineering and clinical cardiac research. For consortium builders, they bring both the technology and the project leadership experience of having coordinated multiple H2020 projects.

Highlights from their portfolio

• SAMBAfun
  Their flagship project (EUR 1.1M) developing a complete accelerometer-based cardiac function assessment system — represents the core of their commercial product ambition.
• MATPASE
  Focused on solving a critical manufacturing bottleneck — biocompatible encapsulation materials for cardiac implant leads and sensors — essential for moving from prototype to market.
• CARDISENSE
  Their SME Phase 1 entry point (2015) that launched the entire cardiac sensor product line, demonstrating the feasibility that enabled all subsequent projects.